WISA - Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket | Benzinga
Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million upfront all cash deal.
Coherus BioSciences shares jumped 22.1% to $2.98 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- Northann Corp. (NYSE: NCL) shares jumped 19.9% to $1.63 in pre-market trading after jumping over 25% on Friday.
- HNR Acquisition Corp (NYSE: HNRA) gained 15.4% to $2.48 in pre-market trading.
- Porch Group, Inc. (NASDAQ: PRCH) gained 15.4% to $2.55 in pre-market trading.
- TC Biopharm (Holdings) Plc (NASDAQ: TCBP) surged 15% to $2.69 in pre-market trading after gaining over 10% on Friday. TC BioPharm recently regained compliance with Nasdaq minimum bid price requirement.
- Remark Holdings, Inc. (NASDAQ: MARK) shares climbed 12.7% to $0.4340 in pre-market trading after falling more than 10% on Friday.
- Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares gained 11.8% to $0.9690 in pre-market trading.
- Aclaris Therapeutics, Inc. (NASDAQ: ACRS) gained 10.5% to $1.26 in ...